Shareholders’ Equity (Deficit) (Details) - USD ($)									1 Months Ended			12 Months Ended
	Aug. 05, 2022	Aug. 02, 2022	Jul. 08, 2022	Mar. 23, 2022	Feb. 09, 2022	Oct. 08, 2021	Oct. 08, 2021	Mar. 26, 2021	Aug. 23, 2022	Jul. 29, 2022	Mar. 26, 2021	Dec. 31, 2022	Dec. 31, 2021	Sep. 15, 2022	Feb. 16, 2022	Jul. 29, 2020
Shareholders’ Equity (Deficit) (Details) [Line Items]
Allocation shares, authorized												1,000	1,000
Allocation share in percentage												100.00%
Profit allocation percentage												20.00%
Allocation shares												1,000
Common shares, issued					289,772	62,500	62,500					500,000,000	500,000,000
Common shares, outstanding													1,210,918
Issued aggregate share											99,710
Issued per share (in Dollars per share)								$ 1.9			$ 1.9
Purchase price per unit (in Dollars)						$ 24,362,800		$ 1.65
Issued common shares								99,710			99,710			126,669	38,096
Other underwriting expense		1,428,572
Gross purchase price (in Dollars per share)		$ 4.2
Public offering	1,428,572
Gross proceeds (in Dollars)	$ 6,000,000
Net proceeds amount (in Dollars)	$ 5,150,000
Common stock issued				249,762					505,751	337,841
Convertible promissory notes												6.00%
Dividend of per share (in Dollars per share)				$ 0.05					$ 0.13125	$ 0.13125
Exercise price per share (in Dollars per share)			$ 5.2										$ 10
Exercise price amount (in Dollars)													$ 4.2
Warrants description													The assumptions used in the model were as follows: (i) dividend yield of 0%; (ii) expected volatility of 62.5-63.25%; (iii) weighted average risk-free interest rate of 0.16%; (iv) expected life of three years; (v) estimated fair value of the common shares of $10.40-$21.00 per share; and (vi) various probability assumptions related to redemption, calls and price resets. The amount allocated to the warrants, based on their relative fair of $1,472,914, was recorded as additional paid-in capital.
Common stock exercise price (in Dollars per share)												$ 4.2
Warrant term description													The warrants have a term of three years and are callable by the Company after one year if the 30-day average stock price is in excess of $5 and the trading volume in the Company’s shares exceed 100,000 shares a day over such period. The Company can also redeem the warrants during the term for $0.50 a warrant in the first year; $1.00 a warrant in the second year; and $1.50 a warrant in the third year.
Exercise price per share (in Dollars per share)						$ 0.04	$ 0.04
Warrant for purchase shares							125,000
Price per share (in Dollars per share)							$ 10
Exercise price per share (in Dollars per share)							$ 4.2
Exercise price per share (in Dollars per share)												$ 12
Adjusted exercise price			4.2									4.2
Consolidations adjustments to conversion price, description												The assumptions used in the model were as follows: (i) dividend yield of 0%; (ii) expected volatility of 51.81%; (iii) weighted average risk-free interest rate of 0.31%; (iv) expected life of three years; (v) estimated fair value of the common shares of $7.76 per share; and (vi) various probability assumptions related to redemption, calls and price resets. The fair value of the warrants was $379,533, or $3.15 per warrant, resulting in the amount allocated to the warrants, based on their relative fair of $172,050, was recorded as additional paid-in capital.
Warrant description												The warrants allow the holder to purchase one (1) common share at an exercise price of $4.20 per common share (subject to adjustment including upon any future equity offering with a lower exercise price), which may be exercised on a cashless basis under certain circumstances. The Company may force the exercise of the warrants at any time after the one year anniversary of the date of the warrants, if (i) the Company is listed on a national securities exchange or the over-the-counter market, (ii) the underlying common shares are registered or the holder of the warrant otherwise has the ability to trade the underlying common shares without restriction, (iii) the 30-day volume-weighted daily average price of the common shares exceeds 200% of the exercise price, as adjusted, and (iv) the average daily trading volume is at least 100,000 common shares during such 30-day period. The Company may redeem the warrants held by any holder in whole (but not in part) by paying in cash to such holder as follows: (i) $0.50 per share then underlying the warrant if within the first twelve (12) months of issuance; (ii) $1.00 per share then underlying the warrant if after the first twelve (12) months, but before twenty-four (24) months of issuance; and (iii) $1.50 per share then underlying the warrant if after twenty-four months, but before thirty-six (36) months.
Conversion price (in Dollars per share)			$ 600,000									$ 0.03				$ 10
Common shares purchase			100,000
Exercise price per share (in Dollars per share)	$ 5.25		$ 6
Total net proceeds (in Dollars)			$ 499,600
Purchase of common shares	35,715											295,427
Dividend yield percentage			0.00%
Expected volatility percentage			49.11%
Weighted average risk-free interest rate			3.13%
Expected life			5 years
Common share, per share			7.23
Fair value of warrants (in Dollars)			$ 2,405,306
Warrants price per share (in Dollars per share)			$ 6.01
Additional paid-in capital (in Dollars)			$ 402,650
Dividend income (in Dollars)			$ 6,400,000
Exercise price per share (in Dollars per share)					$ 4.2							$ 4.2
Deemed dividend (in Dollars)												$ 2,600,000
Issuance of common shares												1,683,005
Weighted average remaining contractual life												1 year 5 months 4 days
Intrinsic value (in Dollars)												$ 108,750
Common Stock [Member]
Shareholders’ Equity (Deficit) (Details) [Line Items]
Common shares, issued												4,079,137
Common shares purchase												1,428,572
Maximum [Member]
Shareholders’ Equity (Deficit) (Details) [Line Items]
Exercise price per share (in Dollars per share)												$ 4.2
Minimum [Member]
Shareholders’ Equity (Deficit) (Details) [Line Items]
Exercise price per share (in Dollars per share)												$ 4.2
Series A Senior Convertible Preferred Shares [Member]
Shareholders’ Equity (Deficit) (Details) [Line Items]
Common stock issued upon acquisition															133,333
Leonite [Member]
Shareholders’ Equity (Deficit) (Details) [Line Items]
Common stock issued		800,000
Convertible promissory notes		6.00%
Kyle’s Sellers [Member]
Shareholders’ Equity (Deficit) (Details) [Line Items]
Common stock issued		189,815
Bevilacqua PLLC [Member]
Shareholders’ Equity (Deficit) (Details) [Line Items]
Common stock issued		285,067
J.H. Darbie & Co [Member]
Shareholders’ Equity (Deficit) (Details) [Line Items]
Adjusted exercise price			4.2
Exercise price per share (in Dollars per share)			$ 7.5
Purchase of common shares			3,600
Mast Hill Fund, L.P. [Member]
Shareholders’ Equity (Deficit) (Details) [Line Items]
Adjusted exercise price			5.2